Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

7.67
-0.2700-3.40%
Volume:363.82K
Turnover:2.80M
Market Cap:668.49M
PE:-3.60
High:8.21
Open:7.87
Low:7.56
Close:7.94
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.70
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:1.55
PE(LYR):-4.10

Loading ...

Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]